Aligos Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
6.24M
on 2026-06-30, from 3.03M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-25 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
1.3 quarters
$30.4M on 2026-06-30 ÷ $23.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-02-11 | Private placement incl. 1.92M pre-funded | 3,349,511 | not read | $105.0M | 8-K ↗ |